Categories: Market Watch

GBB Drink Labs Initiates $53 Million Lawsuit Against FSD Biosciences Inc. For Trade Secret Misappropriation

Miami, FL, December 5, 2023 — GBB Drink Labs, a leader in innovative beverage solutions, has officially filed a lawsuit against FSD Biosciences Inc. in response to the blatant non-compliance with a Cease-and-Desist letter issued on April 14th, 2023. The lawsuit, formally submitted on May 1st, 2023, in the U.S. District Court for the Southern District of Florida, seeks $53 million in damages for a material breach of a mutual nondisclosure agreement and trade secret misappropriation.

The legal action stems from seven months of collaborative discussions between GBB Drink Labs and FSD Pharma, exploring a business opportunity related to GBB’s groundbreaking blood alcohol detoxification drink. FSD Pharma’s public disclosure of the misappropriation of GBB’s trade secrets, without crucial information, during the launch of a new research and development program has led to the initiation of legal proceedings.

The lawsuit alleges that FSD Pharma not only misused GBB’s proprietary and confidential material to attract capital and renowned entrepreneurs but also artificially inflated the price of FSD Pharma’s publicly traded stock. GBB Drink Labs, responding strongly to these actions, is seeking compensatory and punitive damages, coupled with an injunction to prevent any further unlawful disclosure and use of GBB’s trade secrets.

The case, officially titled GBB DRINK LAB, INC. v. FSD BIOSCIENCES INC., has been assigned case number 0:23-cv-60800-AHS in the U.S. District Court for the Southern District of Florida.

For more information on the case, please visit www.sinkingstocks.com.

About GBB Drink Labs: GBB Drink Labs boasts a patented formula that accelerates the process of converting alcohol to sugar in the body, facilitating rapid blood alcohol detoxification. The company has dedicated years to developing a proprietary drink, culminating in a successful acquisition of its patents by Jupiter Wellness, Inc. The closing date for the acquisition is set for August 11th, 2023, with Jupiter Wellness proudly introducing the world’s first rapid blood alcohol detoxification product, “Safety Shot.”

Information contained on this page is provided by an independent third-party content provider. eTrendystock make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please email at contact@etrendystock.com

BTW

Recent Posts

Former Marine Engineer Turned Supply Chain Executive Releases “From Engines to Algorithms,” Charting a New Framework for Operational Constraints

Los Angeles, California, 22nd July 2026 — Niraj Jha, Senior Director of Logistics at Niagara…

4 days ago

Inveslo Appoints Benjamin Ajimoko as Country Manager for Nigeria

Lagos, Nigeria, July 21, 2026, ZEX PR WIRE — Inveslo is pleased to announce the…

6 days ago

Allbridge Core Exploit: $1.65M Drained, Bridge Paused

Allbridge paused its Core cross-chain stablecoin bridge on July 19 after an attacker pulled roughly…

6 days ago

Where GCC’s Most Consequential Business Decisions Get Made

AJMS Group and Marmin AI launch the CXO Boardroom Series in Dubai, a curated executive…

1 week ago

GivTrade’s UAE CMA Category 5 Licence Brings Greater Transparency and a More Verified, User-Friendly Trading Experience

Broker confirms UAE and Mauritius licences cover distinct parts of its business, while independent reviews…

2 weeks ago

Caladan Extends Aggregated Digital Asset Liquidity to zerohash’s Ecosystem

Integration expands the diversity of liquidity available to banks, brokerages, and fintechs powered by zerohash…

2 weeks ago